chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I had flu like symptoms for 24 hours afterwards. My arm swelled up from shoulder to elbow. I had a bright red rash that started to go away and then came back and got worse over two weeks. I have a half dollar size lump at the injection site that showed up 24 hours after the vaccine - hard like bone. Not hard like a muscle knot or something. Hot to touch  - the whole rash area and itching. I went to  Urgent care  on the 21st -after it didn't go away in two weeks. They prescribed Cephalexin to take 1000 mg twice  a day for a week. The rash is mostly gone and heat is gone but lump is still there.  And followed up on Sunday 29th. The doctor said that the hard lump might be permanent. Doctor said the rash part looked like Cellulitis. Rash and fever are gone but lump is still there.
numbness in lt arm & tingling in lt hand, & pain in hand are reported in a pt receiving 1 dose of fluogen vax; pt recvd fluogen in lt deltoid on 18OCT93 & 26OCT93 reported exp above sx; sx cont to persist as of 4NOV93; pain has inc in hand
DEMAND ISCHEMIA 6/4/2021 ATHEROSCLEROSIS OF AORTA CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/12/2021 ATHEROSCLEROSIS OF AORTA DEMAND ISCHEMIA 6/4/2021 DIASTOLIC HEART FAILURE, ACUTE CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/12/2021 DIASTOLIC HEART FAILURE, ACUTE DEMAND ISCHEMIA 6/4/2021 ATHEROSCLEROSIS OF AORTA CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 5/12/2021 ATHEROSCLEROSIS OF AORTA
Approx. 18 hours after the patient received his H1N1 vaccine, he got up out of his chair and collapsed. Was taken to ER, diagnosed with a brain aneurysm the size of a dime on the left side of his brain. He is now having left side weakness.
In March 2021, I was sitting down and started feeling sick. I felt like I was going to pass out and if I did not lay down I was going to pass out. I experienced chills and could not get warm. The next morning I was still feeling ill and I went to the doctor's office and I was tested for COVID and my COVID test was negative but I did test positive for the FLU. I was put on medication but do not remember the name of the medication. I stayed in bed the entire time while I was feeling ill. I recovered from the flu a week and a half.
Severe headache.   Extreme chills and shaking multiple instances.   Body temp check twice in 72 degree room has reading of 94.3 and 94.8 despite active and passive rewarming efforts.
6APR91 temp of 104 lasting 4 days red rash lasting 3 or 4 days, mild arthritis couldn't hardly walk lasted 2 days;
Itching all day; Arm is red; her arm is off and on; This spontaneous case was reported by a consumer and describes the occurrence of MOVEMENT DISORDER (her arm is off and on), PRURITUS (Itching all day) and ERYTHEMA (Arm is red) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     Concurrent medical conditions included Joint pain.    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced MOVEMENT DISORDER (her arm is off and on). On 04-Feb-2021, the patient experienced PRURITUS (Itching all day) and ERYTHEMA (Arm is red). At the time of the report, MOVEMENT DISORDER (her arm is off and on) and ERYTHEMA (Arm is red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment information was provided.   Reporter did not allow further contact
The vaccine was injected in my right arm. There was redness that occurred after several days but on the fourth day about an inch below the injection site, the redness widened to a patch 2" x 5" and was very warm to touch. An irregular shaped hard lump formed underneath the skin, and about one week after injection it became very itchy. I put Arnica, a natural inflammatory, on the area on my arm and after two days it wast better, less swollen and itchy.
I just spent 6 days in the hospital with covid; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (I just spent 6 days in the hospital with covid) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COVID-19 (I just spent 6 days in the hospital with covid) (seriousness criterion hospitalization). The patient was hospitalized for 6 days due to COVID-19. At the time of the report, COVID-19 (I just spent 6 days in the hospital with covid) outcome was unknown.            No concomitant medication was reported.  No treatment information was provided.; Sender's Comments: Based on the mechanism of action of mRNA-1273 causal association between the event of COVID-19 infection and mRNA-1273 is assessed as not applicable. Follow up form was sent to clarify if it could be a "lack of efficacy" event.
PT PRESENTED TO RECEIVE 2ND DOSE OF PFIZER VACCINE. ANSWERED NO TO THE QUESTION: In the last 10 days, have you had a COVID-19 test because you had symptoms and are still awaiting your test results or been told by a health care provider or health department to isolate or quarantine at home due to COVID-19 infection or exposure? AFTER PT RECEIVED VACCINE AND LEFT THE CLINIC IT WAS DISCOVERED THAT SHE WAS REPORTED AS TESTING POSITIVE FOR COVID, TESTED 8/16/21 AT WELLNOW URGENT CARE ACCESSION NUMBER WNY01405105. NOTIFIED EXPOSED STAFF AND MEDICAL PROVIDER ON CALL. NO OTHER PTS HAD CLOSE CONTACT. NO IMMEDIATE ADVERSE REACTIONS REPORTED BY PT AFTER RECEIVING VACCINE. CALLED PT TO INFORM HER THAT IT IS NOT RECOMMENDED TO GET VACCINE DOSE WHILE COVID+ DUE TO RISK OF EXPOSING OTHER UNVACCINATED PTS TO COVID, AND POSSIBILITY OF SIDE EFFECTS. RECOMMENDED PT CALL HER HEALTHCARE PROVIDER IF SHE HAS ANY CONCERNS ABOUT SIDE EFFECTS THAT OCCUR.
Information was received 13-OCT-2016 via telephone call from a registered nurse who reported that an improperly stored dose of Haemophilus b Conjugate Vaccine (Meningococcal Protein Conjugate) was administered to a 10 week old patient on 10-OCT-2016. The reported lot numbers are: # M014925, expiration date 16-FEB-2019 and Lot # M010439, expiration date 08-DEC-2018. It was not specified which lot # was administered to this patient. No adverse effects reported. This report was due to data logger. This is one of several reports from the same source. Additional information was requested.
Possible cellulitis; Md prescribed cephalexin; Pt noticed  red circle getting bigger.
Patient was  likely administered vaccine IM instead of subQ given thin arms and minimal arm fat. There have been no known adverse events from this administration. Pt tolerated injection and left facility with no adverse reactions.
colleague was given MMR in early am and states by that evening around 8pm she started to develop redness and some itching to R arm, but not at injection site. The rash has become increasingly red and painful and has spread from R wrist to upper R arm. Little blisters had begun to develop by this am when the colleague reported the reaction to employee health. I sent her to urgent care where they ordered a prednisone 10 mg dose pack x 6 days. She is to also use topical cream for itching as needed.
Headache, chills, fever up to 101.9, body ache, fatigue , dirreah
Vaccine exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) in a 35-year-old female patient (gravida 2, para 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Drug allergy.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. The patient's last menstrual period was in September 2020 and the estimated date of delivery was 17-Jul-2021. On 03-Mar-2021, the patient experienced EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy). The patient received mRNA-1273 (Moderna COVID-19 Vaccine) during pregnancy.  At the time of the report, EXPOSURE DURING PREGNANCY (Vaccine exposure during pregnancy) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       no relevant concomitant medications was reported. No treatment information was provided   Reporter did not allow further contact
Starting the day after vaccine I have had extreme fatigue, nausea, decreased appetite. dizziness, muscle aches, chills.  It has continued now for 14 days, without improvement.  It is actually worsening.
I have an injection site reaction that appeared about 10 days after the shot.  It did not appear in the immediate days following the shot. There is a raised, red, warm spot on my left shoulder that is 2.5-3 inches in diameter.  It is warm to the touch, but I do not have a fever.
Menactra given improperly subcutaneously, lower area of right upper arm.  Immediate pain with raised red rash rapidly developing and increasing in diameter to three inches by three days, with axillary pain with adenopathy and fever.  Rash and axillary pain resolved after one week, however persistent daily temps. 99.5 to 100.1 continue now with general malaise and extreme fatigue.  No improvement with initial Keflex and later Medrol treatment.  Menomune had been given previously 5/04 without incident.
3 YO received Kinrix; This case was reported by a other health professional via call center representative and described the occurrence of inappropriate age at vaccine administration in a 3-year-old male patient who received DTPa-IPV (Kinrix) (batch number 3KS4F, expiry date 22nd March 2024) for prophylaxis.   Co-suspect products included dtpa-ipv vaccine pre-filled syringe device (Kinrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 18th November 2022, the patient received the 1st dose of Kinrix and Kinrix Pre-Filled Syringe Device. On 18th November 2022, unknown after receiving Kinrix and Kinrix Pre-Filled Syringe Device, the patient experienced inappropriate age at vaccine administration. On an unknown date, the outcome of the inappropriate age at vaccine administration was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 23-Nov-2022 Reporter's comment: The medical assistant called in to reported that a dose of Kinrix had been administered to a patient that was younger than the age group mentioned in the prescribing information. Personal information was collected form the reporter but they declined for it to be stored into their database. Information about the patient was collected, except for the patient's initials, which the health care professional stated was not available at the moment. At the site from which the reporter called. The call was escalated to second line. The vaccine administration facility was the same as primary reporter. The reporter consented to follow-up. Additional supportive information: The patient received a dose of Kinrix at inappropriate age, which led to inappropriate age at vaccine administration.
sore arm for 12 hours; This is a spontaneous report from COVAX SUPPORT. A contactable male consumer (patient) reported for his self. A 62 years-old male patient received first dose of BNT162B2 (Pfizer BioNTech Covid 19 vaccine, formulation: Solution for injection, batch/lot number: unknown) via unknown route of administration, 22 days ago as DOSE 1, SINGLE for COVID-19 immunisation. The patient's medical history and concomitant medication was not reported. After the vaccine the patient had a sore arm for 12 hours. The patient's daughter suggested he drink a lot of water and taking a tylenol before the vaccine and it was a non-issue the first time around. The patient was to get his second dose today but was wondering what would happen if he was asymptomatic and receives the second dose of the vaccine. What adverse effects could occur between having the actual covid virus and then receiving the vaccine? Aren't you supposed to wait 90 days after having covid to get the vaccine? What if you're asymptomatic and don't know? The outcome of the event was unknown.  The lot number for the vaccine, [BNT162B2 was not provided and would be requested during follow up.
Pain over deltoid and bicep, could not raise arm over head, redness spreading inward around arm, and hot.
This case was reported by a consumer and described the occurrence of sleep loss in a male patient who received DTPa (Reduced antigen). On an unknown date, the patient received dTpa vaccine at an unknown date. On an unknown date, unknown after receiving dTpa vaccine, the patient experienced sleep loss and joint pain. On an unknown date, the outcome of the sleep loss and joint pain were unknown. It was unknown if the reporter considered the sleep loss and joint pain to be related to dTpa vaccine. Additional information received: Patient experienced some symptoms following his Tdap vaccination that were not listed as common side effects. He experienced sleep loss and joint pain and is continuing to have symptoms and treat for these symptoms.
Narrative:  80yo male patient died on 12/26/2021 at nursing home (NON-AGENCY facility) under NH placement. Pt had the following: COPD on home 2L O2 NC, SCLC, HFpEF (EF 45 %), CAD, HTN, & T2DM. Pt had received covid vaccines on 2/12/21 & 3/12/21. This death is likely not related to the vaccinations due to patient's comorbidities, advanced age, and length of time from vaccine administration.
fever of 101.6; Fatigue; Headache; Sore Arm of injection site; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 80-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included type i diabetes mellitus.   On 12th November 2020, the patient received the 1st dose of Shingrix (intramuscular). On 12th November 2020, less than a day after receiving Shingrix, the patient experienced injection site pain, fatigue and headache. On 13th November 2020, the patient experienced fever. On 14th November 2020, the outcome of the fever was recovered/resolved. On an unknown date, the outcome of the injection site pain and headache were unknown and the outcome of the fatigue was not recovered/not resolved.   It was unknown if the reporter considered the injection site pain, fever, fatigue and headache to be related to Shingrix.  Additional details were provided as follows: The patient received Shingrix in the left arm. The patient experienced sore arm at injection site. On 13th November 2020, 1 days after vaccination, the patient had a fever of 101.6 degree F. On 14th November 2020, the patient's temperature was normal. The patient continued to feel fatigue. All information was not available. The reporter consented to follow up.
This spontaneous report as received from a nurse refers to unspecified number of patients of unknown age and gender. The patient's current conditions and medical history were not reported. On unspecified dates, the patients were vaccinated with unspecified doses of improperly stored GARDASIL (unknown strength and route). Concomitant medications were not reported. No adverse effect was reported. The outcome of the events was unknown. There was no product quality complaint involved. This is one of several reports received from the same reporter. Additional information has been requested.
achiness in his legs and hands; Chills; Fatigue; injection site swelling and achiness; injection site swelling and achiness; This is a spontaneous report from a contactable consumer via the Pfizer-sponsored program.   A 45-years-old male patient received bnt162b2 (BNT162B2; Batch/lot number: EK4176), via an unspecified route of administration at left arm on 13Jan2021 at SINGLE DOSE for covid-19 immunisation.  Medical history reported as none.  There were no concomitant medications.  The patient experienced fatigue on 17Jan2021 with outcome of not recovered, achiness in his legs and hands on 18Jan2021 with outcome of not recovered, chills on 18Jan2021 with outcome of not recovered, injection site swelling and achiness on 13Jan2021 with outcome of recovered on 14Jan2021. The patient reported after he got the first COVID vaccine on 13Jan2021 he experienced fatigue, achiness, and injection site swelling. Patient wanted to know if this is normal after the first dose and this was discussed. Patient explained that the fatigue - this didn't start until 17Jan2021 and was ongoing. On 18Jan2021 he starting having achiness in his legs and hands and he also had a few chills today. The injection site swelling and achiness there, was gone after the 14Jan2021. Patient was really looking for an answer to his question on if it was normal or should he get a COVID test. He was on day 5 after getting the vaccine and from what he read most people have side effects within a 24 hours and gone within 48 hours. Some of his side effect didn't start until 4 days later. The Vaccination Facility Type was hospital. History of all previous immunization with the Pfizer vaccine considered as suspect was none. Additional Vaccines Administered on Same Date of the Pfizer Suspect was none. Patient did not go to Emergency Room or Physician Office. There was no Prior Vaccinations (within 4 weeks).
Patient reports symptoms resembling Bell's Palsy. Unilateral drooping of facial features.
Treatment of COVID-19; Treatment of COVID-19; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 47-year-old male patient received BNT162b2 (BNT162B2), on 15Oct2021 as dose 3 (booster), single (Lot number: ewo277) at the age of 46 years, in left arm for covid-19 immunisation; coviD-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) and as dose 2, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing); "Sleep apnea" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), and all described as "Treatment of COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive, notes: COVID 19 Treatment; Negative, notes: testing negative; Positive, notes: Rebound positive test. Therapeutic measures were taken as a result of drug ineffective, covid-19. The patient received Paxlovid as treatment for the event from 15Feb2023 to 19Feb2023. Outcome of the events was not recovered.
Covid-19 Pfizer Tris-Sucrose 6mo-4yr (Maroon Cap) was drawn up incorrectly and patient received lower than authorized dose. Patient will return to office for repeat vaccination.
fever as high as 101 F (now down to 97 F); body aches; chills; shaking; This is a spontaneous report from a contactable consumer (patient). A 57-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration on 07Jan2021 at single dose for COVID-19 immunisation. Medical history included tested COVID positive from 27Dec2020. The patient's concomitant medications were not reported. Historical vaccine included first dose of vaccine on 17Dec2020. The patient started having symptoms on 23Dec2020 and tested COVID positive on 27Dec2020. Received the second dose of vaccine on 07Jan2021 and then was "having reaction to vaccine", experiencing the following: fever as high as 101 F (now down to 97 F), body aches, chills, shaking, "as I did when I had COVID". The patient said her coworkers are "experiencing the same things". Fever had resolved while the outcome of the remaining events was unknown.  Information about batch/lot number has been requested.; Sender's Comments: Linked Report(s) : -2021021949 Same patient/reporter/drug
Severe Headache. Head feels like it's swelling. Have a hard time doing anything.
Breakthrough case admission after 3 vaccines Pfizer 3/27/21 lot# Er8732; Pfizer 4/17/21 lot# EW0169;  Pfizer 11/16/21 lot# FH8030
This spontaneous report as received from a certificate medical assistant refers to a 6 month old patient. On 06-DEC-2013 the patient was vaccinated with the third dose of oral ROTATEQ (lot # unspecified) (dosage information and routed unspecified). Date of first two doses are unspecified. On approximately 06-DEC-2013, the patient experienced vomiting immediately after vaccination. It was unknown if the patient had sought medical attention. The outcome of vomiting was unknown. The relatedness between the therapy and the event was unspecified. This is one of several reports received from same source. Additional information has been requested.
Being an RN, the injection hurt more than it should have. I was concerned it was too high. It did lessen in pain until during the night and I could not hardly move my arm, especially in a raising it straight out to my side. I went back to the pharmacy and showed them how limited my movement was. I read the side effects for both the 13 and 23. The 13 mentions limited arm movement. The 23 made NO mention. So for days I had very limited movement. There were certain movements you should be able to do with your shoulder and I could not without severe sharp pains. It began to get more motion but somethings still hurt. I am still a working RN full time and this is not helping me. Today 3 months later I am having issues with movement and pain.
Static Epileptic Seizure for 5-6 hours, irritability, lethargy, and neurologic regression shortly thereafter for several months.
She started feeling warm for few days then the 13th she was with a fever that lasted 3 days.  After that she started getting red spots. Swollen hands, legs, face lips, eyes, her legs turned purple then back to normal and purple again, she was very cold then hot, her heart was beaten very fast, she was weak and pale. She was very itchy and uncomfortable with pain. These are some of symptoms that I can remember right now. This doctor put my baby to suffer and that is not right because she knew the baby was allergic because I told her and is on her file too.  She should had explained to me what the ingredients of the vaccine and the reaction that this can have on an allergic person and main thing she should have listened to me when I said "my baby is allergic to egg, soy and bean" and when I asked her to call doctor too.
Hospitalized 10/23/2021; COVID-19 positive 10/22/2021; fully vaccinated   Admission Date: 10/23/2021 Discharge Date: 10/27/2021   DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Weakness [R53.1] Generalized weakness [R53.1] COVID-19 virus infection [U07.1]   HOSPITAL COURSE: Patient is an 80-year-old male who had presented to the Emergency Room with a one-week complaint of weakness and ataxia. He was seen the day before assess secondary to fall which she had had a CT scan of the head and there are any acute findings sore discharged home. On the day of presentation his weakness was profound is there for return to the emergency room. He was found to have COVID-19 but did not have any respiratory symptoms. And during his hospital stay urine culture was positive for Enterobacter and treated with IV antibiotics. Urine culture susceptibility report did show susceptibility to Cipro ; therefore his antibiotics were transitioned to IV Cipro and upon discharge he is being placed on oral Cipro. He does self cath for urinary retention twice a day. His presenting weakness did improve and he was self ambulating without any difficulty. He has been discharged in stable condition. Discharge recommendations were discussed with the patient and he verbalized understanding and was agreeable.